HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls.

Abstract
Findings from epidemiological, pharmacotherapeutical, genetic and neurobiological studies suggest a possible overlap in the neurobiology of generalized social anxiety disorder (gSAD) and panic disorder (PD). Previously we have found a rapid intravenous m-CPP challenge of 0.1 mg/kg to be highly sensitive and selective in the provocation of panic attacks in patients with PD. We therefore directly compared the behavioural, neuroendocrine and physiological effects of this rapid m-CPP challenge in a small sample of patients with gSAD, patients with PD and matched healthy controls. Panic attacks were significantly more provoked in patients with PD (85%), but not in patients with gSAD (14%) as compared to healthy controls (0%). Effects on the other behavioural parameters, but not on the neuroendocrine and physiological parameters, were significantly greater in patients with PD compared to patients with gSAD and controls. Our preliminary data do not support a shared neurobiology of gSAD and PD.
AuthorsJ F Van Veen, N J A Van der Wee, J Fiselier, I M Van Vliet, H G M Westenberg
JournalEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology (Eur Neuropsychopharmacol) Vol. 17 Issue 10 Pg. 637-42 (Oct 2007) ISSN: 0924-977X [Print] Netherlands
PMID17481859 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Piperazines
  • Serotonin Receptor Agonists
  • Growth Hormone
  • 1-(3-chlorophenyl)piperazine
  • Hydrocortisone
Topics
  • Adult
  • Anxiety Disorders (drug therapy, metabolism, physiopathology)
  • Female
  • Growth Hormone (metabolism)
  • Humans
  • Hydrocortisone (metabolism)
  • Injections, Intravenous (methods)
  • Male
  • Middle Aged
  • Pain Measurement (drug effects)
  • Panic Disorder (drug therapy, metabolism, physiopathology)
  • Piperazines (administration & dosage)
  • Serotonin Receptor Agonists (administration & dosage)
  • Single-Blind Method
  • Statistics, Nonparametric
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: